Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Report
Comprehensive engineering of a therapeutic neutralizing antibody targeting SARS-CoV-2 spike protein to neutralize escape variants
Taichi Kuramochia Chugai Pharmaceutical Co. Ltd., Fuji Gotemba Research Laboratories, Komakado, Gotemba, Shizuoka, JapanCorrespondence[email protected]
https://orcid.org/0000-0001-7242-7124View further author information
https://orcid.org/0000-0001-7242-7124View further author information, Siok Wan Ganb Chugai Pharmabody Research Pte. Ltd., Singaporehttps://orcid.org/0000-0002-6982-4492View further author information
https://orcid.org/0000-0002-6982-4492View further author information, Adrian W.S. Hob Chugai Pharmabody Research Pte. Ltd., Singaporehttps://orcid.org/0000-0002-6501-5196View further author information
https://orcid.org/0000-0002-6501-5196View further author information, Bei Wangc Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR)https://orcid.org/0000-0002-3112-7341View further author information
https://orcid.org/0000-0002-3112-7341View further author information, , , , , , , Dan Chenb Chugai Pharmabody Research Pte. Ltd., Singaporehttps://orcid.org/0000-0002-2790-5606View further author information
https://orcid.org/0000-0002-2790-5606View further author information, Wen-Hsin Leec Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR)https://orcid.org/0000-0003-0315-7495View further author information
https://orcid.org/0000-0003-0315-7495View further author information, Eve Zi Xian Ngohc Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR)https://orcid.org/0000-0001-5407-0280View further author information
https://orcid.org/0000-0001-5407-0280View further author information, Siti Nazihah Mohd Sallehc Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR)https://orcid.org/0000-0002-6110-7472View further author information
https://orcid.org/0000-0002-6110-7472View further author information, Cheng-I Wangc Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR)https://orcid.org/0000-0001-9170-2996View further author information
https://orcid.org/0000-0001-9170-2996View further author information, & Hideaki Shimadab Chugai Pharmabody Research Pte. Ltd., Singaporehttps://orcid.org/0000-0003-4932-1385View further author information
https://orcid.org/0000-0003-4932-1385View further author information show all